Department of Pediatric Cardiosurgery, Bambino Gesù Hospital, Rome, Italy.
Curr Drug Targets. 2009 Dec;10(12):1179-83. doi: 10.2174/138945009789753192.
Septic acute kidney injury (AKI) occurs between 15% and 20% of all intensive care unit admissions and its mortality ranges from 20% to 60%. The incidence and mortality of septic AKI has remained high throughout the last 10 years, whereas our understanding of septic AKI pathogenesis has remained limited. Current evidence about the pathophysiology of septic AKI will be reviewed and areas that require further investigation will be discussed. Improvement of knowledge about this condition seems to be most important in order to find valid diagnostic exams to exactly identify septic AKI and effective therapies to treat it: both of them are currently lacking. Finally, new preventive strategies might be experimented in order to protect critically ill patients from septic AKI.
脓毒症急性肾损伤(AKI)在所有重症监护病房(ICU)入院患者中占 15%至 20%,其死亡率在 20%至 60%之间。在过去的 10 年中,脓毒症 AKI 的发病率和死亡率一直居高不下,而我们对其发病机制的认识仍然有限。本文将对脓毒症 AKI 的病理生理学的现有证据进行回顾,并讨论需要进一步研究的领域。为了找到准确识别脓毒症 AKI 的有效诊断检查和治疗方法,改善对该疾病的认识似乎是最重要的:目前这两方面都有所欠缺。最后,可能会尝试新的预防策略,以保护危重症患者免受脓毒症 AKI 的影响。